Hjem › Fokal segmental glomerulosklerose › Georgia
Fokal segmental glomerulosklerose kliniske forsøg i Georgia
6 studier for Fokal segmental glomerulosklerose søger deltagere på steder i Georgia.
Byer i Georgia
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #29, Augusta
- Investigator Site # 1, Lawrenceville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Emory Children's Center, Atlanta
- Coastal Medical Research, LLC, Brunswick
- Southeast Kidney Associates - East Point, East Point
- og 1 flere
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Emory Children's Center- Site Number : 8400020, Atlanta
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Nephrotic Syndrome Study Network
- Emory University and Children's Healthcare of Atlanta, Atlanta
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000NEPTUNE Match Study
- Emory University Hospital - Children's Hospital of Atlanta, Atlanta
Rekrutterer
Alder 1 til 80 · Alle køn · Opdateret 10. jun. 2026 · NCT04571658A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Emory University School of Medicine, Atlanta
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT05183646Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.